Estrogen Hormone Therapy

Restoring Balance Through a Thoughtful, Evidence-Based Approach

Hormonal changes can affect how you feel in ways that are often dismissed or misunderstood — from sleep and mood to energy, metabolism, and overall well-being.

At Radiant You, we take a clear, evidence-based approach to hormone therapy, helping you understand your options so you can make confident, informed decisions about your health.

Why We’re Providing You This Information

At Radiant You, we believe you deserve to understand the science behind your care — not just the recommendations themselves. This overview is designed to give you a clear, balanced understanding of hormone therapy, including both its benefits and its risks.

What Hormone Therapy Can Improve

Relief from Hot Flashes and Night Sweats

Hormone therapy is the most effective treatment for menopausal symptoms, reducing hot flashes by approximately 75%.

Many women notice improvement within 2–4 weeks.

Quality of Life

Hormone therapy has been shown to improve:

Sleep
Mood
Daily functioning

For many women, these changes are meaningful and noticeable.

Bone Health

Hormone therapy helps preserve bone density and reduces fracture risk by approximately 25%.

Metabolic and Heart Health

When started before age 60 or within 10 years of menopause, hormone therapy may:

Reduce risk of heart disease
Improve metabolic health
Lower overall mortality

Timing matters — earlier initiation is associated with the most favorable outcomes.

Understanding the Risks

Breast Cancer

This is often the most common concern — and where context matters.

Estrogen alone (after hysterectomy): may reduce breast cancer risk
Estrogen + progesterone: increases risk from ~6.3% to 8.3% over 20 years

This represents about 2 additional cases per 100 women.

In other words, ~98 out of 100 women will not develop breast cancer due to hormone therapy

Risk varies based on formulation and decreases after stopping therapy.

Important perspective:
Common lifestyle factors — such as obesity, alcohol use, and physical inactivity — increase breast cancer risk by a similar or greater amount.

Blood Clots

Risk depends on how estrogen is delivered:

Oral estrogen: increases clot risk (~3–4x)
Transdermal or pellet estrogen: no meaningful increase

Non-oral options bypass the liver and avoid this effect.

Heart Disease

The effect depends on timing:

Earlier initiation: protective or neutral
Later initiation: may increase risk

Stroke

Slight increase overall
Lower risk under age 60
Lower risk with non-oral estrogen

Why Timing Matters

One of the most important factors in hormone therapy is when treatment begins.

Under Age 60 or Within 10 Years of Menopause

Most favorable benefit-to-risk profile
Symptom relief with potential long-term health benefits

Ages 60–69

May still be appropriate in selected patients
Requires more individualized decision-making

Age 70 and Above

New initiation is generally not recommended
Risks increase and benefits are less consistent

Continuation vs Starting Therapy

Women who started therapy earlier and are doing well may continue beyond age 60
There is no strict age cutoff — but ongoing reassessment is important

How We Approach Treatment at Radiant You

Non-Oral Estrogen When Appropriate

We often recommend:

Patches
Gels
Pellets

These approaches:

Bypass the liver
Avoid increased clotting risk
Provide more stable hormone levels

Progesterone (If Needed)

When required, we typically use micronized progesterone, which is generally well tolerated and has a favorable safety profile.

Dosing Philosophy

Start with the lowest effective dose
Adjust gradually
Aim for physiologic (natural) hormone levels

Understanding Pellet Therapy

Pellets are one of several delivery options and may be a good fit for some patients.

They provide steady hormone delivery over several months.

Potential Advantages

Consistent hormone levels
No daily or weekly dosing
Convenient for certain lifestyles

Things to Consider

Minor in-office procedure required
Cannot be removed once placed
Dose adjustments take time

Some studies show that 40–50% of patients choose not to continue pellets after the first treatment, often due to preferences around flexibility or side effects.

This highlights that pellets can work very well for some patients — but are not the best fit for everyone.

Non-Hormonal Options

For patients who prefer not to use hormone therapy or are not ideal candidates, alternatives include:

Fezolinetant
Certain antidepressants (e.g., venlafaxine, escitalopram)
Gabapentin

These options can help, though they are generally less effective than hormone therapy.

What Happens Without Treatment

Menopausal symptoms can persist for years and may affect:

Sleep
Work performance
Overall quality of life

In some cases — particularly with early menopause — untreated hormone deficiency is associated with increased risk of:

Osteoporosis
Cardiovascular disease

How This Fits Into Your Health

Hormone therapy works best when built on a strong foundation:

Strength training
Sleep
Nutrition
Stress management

And if those areas aren’t fully where you want them to be, that’s exactly where we can help — through a more comprehensive, personalized approach to your health at Radiant You.

Sources & Further Reading

Vasomotor Symptom Relief (~75% Reduction)

Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420 — Comprehensive review confirming HRT as the
most effective treatment for hot flashes and night sweats.

Bone Health (~25% Fracture Reduction)

Bofill Rodriguez M, et al. Long-Term Hormone Therapy for Perimenopausal and Postmenopausal Women. Cochrane Database Syst Rev. 2025;11:CD004143 — Combined
HRT reduced all clinical fractures (RR 0.78); estrogen-only reduced fractures (RR 0.73).

Heart Health and Timing Hypothesis

Rossouw JE, et al. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms. JAMA Intern Med. 2025;185(11):1330-1339 — Most recent WHI secondary analysis confirming cardiovascular safety in women 50-59, caution in 60-69, avoidance in ≥70.

Breast Cancer Risk (Estrogen-Only vs. Combined)

Chlebowski RT, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-Term Follow-Up of the WHI. JAMA.
2020;324(4):369-380 — 20-year follow-up: estrogen-only reduced breast cancer (HR 0.79); combined therapy increased it (HR 1.27).
Collaborative Group on Hormonal Factors in Breast Cancer. Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk. Lancet. 2019;394(10204):1159-
1168 — Meta-analysis of 143,000+ cases; 5-year combined HRT increases 20-year risk from 6.3% to 8.3%.

Stroke/Blood Clot Risk

Mohammed K, et al. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015;100(11):4012-
20 — Oral estrogen associated with higher stroke risk vs. transdermal (RR 1.24).

Age-Stratified Recommendations / Continuation vs. Initiation

Schweitzer K. New Analysis of WHI Data Aims to “Clear the Air” Over Menopausal Hormone Therapy. JAMA. 2025 — Discusses age-stratified approach and continuation
beyond 65 as reasonable with counseling

Pellet Therapy

ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy. Obstet Gynecol. 2023;142(5):1266-1273 — Notes pellets cannot be removed once
placed; 43% discontinuation rate